MedOncMD

To provide the information your oncologist is not telling you or doesn't have the time to!

  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!

Colorectal cancer

Embark on a comprehensive exploration of colorectal cancer within our dedicated ‘Colorectal Cancer’ subcategory. Focused on providing invaluable insights into this common yet intricate form of cancer, our curated content encompasses a spectrum of information. Navigate through articles, expert perspectives, and the latest advancements in research and treatment options specific to colorectal cancer. Whether you’re seeking guidance on early detection, understanding different stages, or exploring supportive care, our ‘Colorectal Cancer’ subcategory is your trusted resource. Empowering individuals, caregivers, and healthcare professionals, we aim to foster awareness and knowledge to navigate the complexities of colorectal cancer. Join us on a journey towards informed decision-making and proactive colorectal health within this specialized arena of oncology

From Observation to Action: How Circulating Tumor DNA Changed One Patient’s Course

Just got back from family spring break vacation and sincerely appreciative of the great feedback I was getting after changing the format of the blog to personal stories from the clinic and every day life as a medical oncologist. I’ll still include updates with FDA approvals or interesting topics from the current news every so …

Read On »

A New Frontier in Metastatic Colorectal Cancer Treatment: FDA Approval of Quad Therapy for BRAF V600E Mutation

On December 20, 2024, the FDA granted accelerated approval for a groundbreaking new treatment approach for patients with metastatic colorectal cancer (mCRC) harboring the BRAF V600E mutation. The newly approved regimen combines encorafenib (Braftovi) with cetuximab and mFOLFOX6 (a chemotherapy regimen consisting of fluorouracil, leucovorin, and oxaliplatin). This marks a pivotal step forward in the …

Read On »

NEJM Study Highlights Breakthrough in MSI-High Colorectal Cancer Treatment with Ipilimumab and Nivolumab

Colorectal cancer remains a significant global health challenge, ranking as the third most common cancer and the second leading cause of cancer-related deaths worldwide. Among metastatic colorectal cancer patients, the subset with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) tumors presents unique opportunities for immunotherapy. The recent CheckMate 8HW trial, published in the New England Journal …

Read On »

New Horizons in Colon Cancer Treatment: Neoadjuvant Immunotherapy for Mismatch Repair–Deficient High Risk Stage II/III Colon Cancer

Colon cancer treatments have long relied on surgery, chemotherapy, and radiation. However, recent breakthroughs in immunotherapy, particularly for mismatch repair–deficient (dMMR) tumors, are reshaping how certain high-risk cancers are treated. A recent study published in The New England Journal of Medicine provides encouraging data on the effectiveness of neoadjuvant immunotherapy for patients with locally advanced dMMR colon …

Read On »

James Van Der Beek’s Colorectal Cancer Diagnosis: A Call to Action for Awareness and Early Detection

In a recent and courageous announcement, actor James Van Der Beek, known for roles in Dawson’s Creek and Varsity Blues, revealed his diagnosis of colorectal cancer. At age 47, Van Der Beek shared that he has been managing this diagnosis privately, taking steps towards treatment with the support of his family. While the specifics indicate …

Read On »

GRANITE Immunotherapy Offers Hope for MSS Metastatic Colorectal Cancer: Improving Progression-Free Survival with Neoantigen-Directed Therapy

Immunotherapy has made significant strides in cancer treatment, but microsatellite stable (MSS) metastatic colorectal cancer (mCRC) has long posed a challenge due to its resistance to immune-based therapies. However, promising results from a recent phase 2/3 trial have shown that the individualized neoantigen-directed immunotherapy, GRANITE, may change the outlook for patients with MSS mCRC. This innovative therapy, combined …

Read On »

New Breakthrough in Colorectal Cancer: KRAS G12C Inhibition with Sotorasib and Panitumumab

Unveiling a New Era in Colorectal Cancer Treatment: The Promise of KRAS G12C Inhibition Colorectal cancer stands as one of the most common and deadly forms of cancer worldwide. Despite advances in treatment, the search for more effective and targeted therapies continues. A significant breakthrough in this quest is the understanding and targeting of specific …

Read On »

Belzutifan FDA Approval: A New Hope for Advanced Renal Cell Carcinoma Patients

On December 14, 2023, the FDA gave the green light to belzutifan (Welireg, Merck & Co., Inc.), offering new hope for individuals battling advanced kidney cancer. It’s like unlocking a powerful tool after trying different strategies. Understanding Belzutifan’s Power Against Kidney Cancer Imagine your body as a bustling city with the kidneys playing the role …

Read On »

A Revolutionary Paradigm Shift to Rectal Cancer Treatment: Insights from the PROSPECT Trial Presented at ASCO 2023

A Revolutionary Paradigm Shift to Rectal Cancer Treatment: Insights from the PROSPECT Trial Presented at ASCO 2023

ASCO 2023 was a ton of fun and lot of learning. In the coming weeks, I’ll share select abstracts that I thought were most important. This article discusses data from a groundbreaking PROSPECT trial which was presented as a Plenary topic at Chicago and published in NEJM last week. Ultimately, this creates more treatment options …

Read On »

Harnessing ctDNA Testing in the NRG-GI008 Trial: A Personalized Approach to Colon Cancer Treatment

Harnessing ctDNA Testing in the NRG-GI008 Trial: A Personalized Approach to Colon Cancer Treatment

Colon cancer is the third most common cancer worldwide, affecting millions of individuals every year. Currently, the treatment paradigm for resected stage 2 and 3 colon cancer patients typically involves surgery followed by adjuvant chemotherapy to reduce the risk of cancer recurrence. However, the prognosis for these patients varies significantly, with some experiencing a complete …

Read On »

  • Page 1
  • Page 2
  • Next

Recent Posts

  • The Story Behind the Logo: Building the Bridge, Stone by Stone
  • Remembering Dr. Craig Kitchens: The Legacy of a Great Physician
  • Six Months Later: Rediscovering Balance Through Locum Life and New Ventures
  • When Delay Becomes Harm: A Clinician’s Reflection on Timely Cancer Care
  • Understanding Disability in Oncology: A Clinician’s Perspective

Categories

  • Art of Oncology (78)
  • Current News (12)
  • Immunotherapy News (9)
  • Navigation Corner (6)
  • Prevention and Healthy Lifestyle (18)
  • Research Advances (108)
    • Clinical Trials (43)
    • Immunotherapy (29)
    • New Treatments and Therapies (42)
  • The essentials (41)
    • Radiology (4)
  • Travel Health (1)
  • Uncategorized (10)
  • Varied Cancer Perspectives (114)
    • Biliary tract cancer (3)
    • Bladder Cancer (3)
    • Breast Cancer (10)
    • Cervical Cancer (2)
    • CNS Cancers (1)
    • Colorectal cancer (13)
    • Esophageal Cancer (2)
    • Gastric cancer (6)
    • Hepatic Tumors (1)
    • Leiomyosarcoma (2)
    • Leukemia (2)
    • Lung Cancer (10)
    • Lymphoma (3)
    • Melanoma (28)
    • Multiple Myeloma (3)
    • Neuroendocrine cancer (2)
    • Ovarian Cancer (3)
    • Pancreatic Cancer (5)
    • Prostate Cancer (4)
    • Sarcoma (2)
    • Sickle Cell Disease (4)
    • Skin Cancer (7)
    • Thyroid cancer (1)
    • Urothelial Cancer (1)
  • Video (2)
  • Weekly Newsletter (6)

Get in touch!

  • Facebook
  • Instagram
  • TikTok
  • LinkedIn


Meet the authors

Dr. Sajeve Thomas
Dr Daniel Landau


Subscribe


  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!
© 2025 MedOncMD. Minimal Theme by SPYR
✕
  • Home
  • Magazine
  • Blog
    • The essentials
    • Art of Oncology
    • Prevention and Healthy Lifestyle
    • Research Advances
    • Navigation Corner
    • Video Library
  • Navigation Corner
  • Meet and Greet
    • About Dr Thomas
    • About Dr Landau
  • Ask MedOncMD?
  • Keep in Touch!